MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
MIMEDX GROUP, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$4.38−0.05 (-1.13%)
Close on Oct 19, 2026
- Market cap
- $647.35M
- P/E (TTM)
- 109.5
- Dividend yield
- –
MIMEDX GROUP, INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regenerative Medicine | – | – | – | – | – | – | – | – | – | – | – | $0 | – | – |
| Wound & Surgical | – | – | – | – | – | – | – | – | – | – | – | $80.38M | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical | $39.30M | $36.37M | $39.42M | $36.63M | $34.13M | $32.13M | $31.55M | $29.01M | $29.66M | $27.66M | $30.85M | $30.56M | 61.1% | +15.1% |
| Wound | $25.07M | $22.62M | $78.68M | $77.10M | $64.48M | $56.07M | $61.36M | $55.05M | $57.55M | $57.05M | $55.98M | $51.16M | 38.9% | -61.1% |
| Section 351 | – | – | – | – | – | – | – | – | – | – | – | $76.00K | – | – |
| Tissue/Other | – | – | – | – | – | – | – | – | – | – | – | $75.57M | – | – |
| Cord | – | – | – | – | – | – | – | – | – | – | – | $6.07M | – | – |
| Other | – | – | – | – | – | – | – | – | – | – | – | $100.00K | – | – |
| Advanced Wound Care | – | – | – | – | – | – | – | – | – | – | – | $81.64M | – | – |
| Hospital | – | – | – | – | – | – | $50.27M | $46.03M | $47.38M | $43.76M | $50.89M | $47.35M | – | – |
| Private Office | – | – | – | – | – | – | $29.51M | $25.59M | $26.96M | $30.33M | $27.60M | $22.95M | – | – |
| Other | – | – | – | – | – | – | $13.13M | $12.44M | $12.87M | $10.62M | $8.34M | $11.41M | – | – |
By region
From the segment and revenue-disaggregation notes of Mimedx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.